CenterStar Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,048
Closed -$437K 419
2026
Q1
$437K Buy
+5,048
New +$484K 0.05% 346
2025
Q2
Sell
-20,317
Closed -$1.83M 317
2025
Q1
$1.83M Buy
+20,317
New +$1.82M 0.44% 59
2023
Q4
Sell
-27,064
Closed -$2.06M 377
2023
Q3
$2.12M Buy
+27,064
New +$2.27M 0.44% 31
2022
Q1
Hold
0
422
2021
Q4
Hold
0
357
2021
Q1
Hold
0
358
2020
Q4
Hold
0
269
2020
Q3
Hold
0
505
2020
Q2
Hold
0
56
2020
Q1
Hold
0
204
2019
Q4
Hold
0
75
2019
Q3
Hold
0
47
2019
Q1
Hold
0
80
2018
Q2
Hold
0
83
2018
Q1
Hold
0
15

Other funds holding MDT

CenterStar Asset Management's MDT Position: Q2 2026 in Review

CenterStar Asset Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 5,048 shares — an estimated $437K sold.

CenterStar Asset Management first reported a position in MDT in Q3 2023 and held it in 3 quarters. The position peaked at $2.12M in Q3 2023. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CenterStar Asset Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • CenterStar Asset Management sold 5,048 Medtronic shares in Q2 2026, an estimated $437K.
  • CenterStar Asset Management first reported a position in Medtronic in Q3 2023 and held it in 3 quarters.
  • CenterStar Asset Management's Medtronic position peaked at $2.12M in Q3 2023.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.